A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
Bristol-Myers Squibb
Bristol-Myers Squibb
Astellas Pharma Inc
PMV Pharmaceuticals, Inc
Mayo Clinic
Dartmouth-Hitchcock Medical Center
Aminex Therapeutics, Inc.
NeoImmuneTech
Genmab
Essen Biotech
Takeda
Dana-Farber Cancer Institute
Seagen Inc.
Transgene
BicycleTx Limited
Strand Therapeutics Inc.
Memorial Sloan Kettering Cancer Center
Maastricht University Medical Center
Scancell Ltd
National University Hospital, Singapore
NuCana plc
Medicenna Therapeutics, Inc.
Mayo Clinic
Roswell Park Cancer Institute
Cedars-Sinai Medical Center
Weill Medical College of Cornell University
Providence Health & Services
Intensity Therapeutics, Inc.
RAPT Therapeutics, Inc.
Sellas Life Sciences Group
Simcha IL-18, Inc.
Essen Biotech
Salubris Biotherapeutics Inc
NGM Biopharmaceuticals, Inc
GeneMedicine Co., Ltd.
Genexine, Inc.
Icahn School of Medicine at Mount Sinai
Kineta Inc.
National Taiwan University Hospital
Tesaro, Inc.
Cedars-Sinai Medical Center
Eisai Inc.
Silverback Therapeutics
Incyte Corporation
Incyte Corporation
Western Regional Medical Center
ETOP IBCSG Partners Foundation
Western Regional Medical Center